Latest period
$86.48B
YoY change
-2.8%
5Y CAGR
-5.3%
Peak year (2019)
$129.94B
Latest annual
$90.04B
Total Assets history chart for Bristol-Myers Squibb (BMY) from 1987 to 2025
Latest: $90.04B
Total Assets growth chart for Bristol-Myers Squibb (BMY) from 1987 to 2025
Latest: -2.8%
Total Assets history table for Bristol-Myers Squibb (BMY) from 1987 to 2025
| 2025 | $90.04B | -2.8% | −$2.56B | ||
| 2024 | $92.60B | -2.7% | −$2.56B | ||
| 2023 | $95.16B | -1.7% | −$1.66B | ||
| 2022 | $96.82B | -11.4% | −$12.49B | ||
| 2021 | $109.31B | -7.7% | −$9.17B | ||
| 2020 | $118.48B | -8.8% | −$11.46B | ||
| 2019 | $129.94B | +271.4% | +$94.96B | ||
| 2018 | $34.99B | +4.3% | +$1.44B | ||
| 2017 | $33.55B | -0.5% | −$156.00M | ||
| 2016 | $33.71B | +6.2% | +$1.96B | ||
| 2015 | $31.75B | -5.9% | −$2.00B | ||
| 2014 | $33.75B | -12.5% | −$4.84B | ||
| 2013 | $38.59B | +7.5% | +$2.69B | ||
| 2012 | $35.90B | +8.9% | +$2.93B | ||
| 2011 | $32.97B | +6.1% | +$1.89B | ||
| 2010 | $31.08B | +0.2% | +$68.00M | ||
| 2009 | $31.01B | +5.2% | +$1.52B | ||
| 2008 | $29.49B | +12.7% | +$3.31B | ||
| 2007 | $26.17B | +2.3% | +$597.00M | ||
| 2006 | $25.57B | -9.1% | −$2.56B | ||
| 2005 | $28.14B | -7.5% | −$2.30B | ||
| 2004 | $30.43B | +10.9% | +$2.99B | ||
| 2003 | $27.45B | +9.7% | +$2.43B | ||
| 2002 | $25.02B | -10.0% | −$2.79B | ||
| 2001 | $27.81B | +58.2% | +$10.23B | ||
| 2000 | $17.58B | +2.7% | +$464.00M | ||
| 1999 | $17.11B | +5.2% | +$842.00M | ||
| 1998 | $16.27B | +8.6% | +$1.29B | ||
| 1997 | $14.98B | +2.0% | +$292.00M | ||
| 1996 | $14.69B | +5.4% | +$756.00M | ||
| 1995 | $13.93B | +7.9% | +$1.02B | ||
| 1994 | $12.91B | +6.7% | +$809.00M | ||
| 1993 | $12.10B | +12.0% | +$1.30B | ||
| 1992 | $10.80B | +14.7% | +$1.39B | ||
| 1991 | $9.42B | +2.2% | +$201.00M | ||
| 1990 | $9.21B | +8.5% | +$718.00M | ||
| 1989 | $8.50B | +2.7% | +$224.00M | ||
| 1988 | $8.27B | +10.1% | +$759.00M | ||
| 1987 | $7.51B | — | — |
- 2025$90.04B-2.8%
- 2024$92.60B-2.7%
- 2023$95.16B-1.7%
- 2022$96.82B-11.4%
- 2021$109.31B-7.7%
- 2020$118.48B-8.8%
- 2019$129.94B+271.4%
- 2018$34.99B+4.3%
- 2017$33.55B-0.5%
- 2016$33.71B+6.2%
- 2015$31.75B-5.9%
- 2014$33.75B-12.5%
- 2013$38.59B+7.5%
- 2012$35.90B+8.9%
- 2011$32.97B+6.1%
- 2010$31.08B+0.2%
- 2009$31.01B+5.2%
- 2008$29.49B+12.7%
- 2007$26.17B+2.3%
- 2006$25.57B-9.1%
- 2005$28.14B-7.5%
- 2004$30.43B+10.9%
- 2003$27.45B+9.7%
- 2002$25.02B-10.0%
- 2001$27.81B+58.2%
- 2000$17.58B+2.7%
- 1999$17.11B+5.2%
- 1998$16.27B+8.6%
- 1997$14.98B+2.0%
- 1996$14.69B+5.4%
- 1995$13.93B+7.9%
- 1994$12.91B+6.7%
- 1993$12.10B+12.0%
- 1992$10.80B+14.7%
- 1991$9.42B+2.2%
- 1990$9.21B+8.5%
- 1989$8.50B+2.7%
- 1988$8.27B+10.1%
- 1987$7.51B—
Total Assets values are taken from Bristol-Myers Squibb's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Assets at Bristol-Myers Squibb (BMY)
According to Bristol-Myers Squibb's latest reported financial statements, the company's latest reported total assets is $86.48B. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and total equity for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Bristol-Myers Squibb (BMY) reported total assets of $90.04B – edged down 2.8% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Bristol-Myers Squibb total assets compounded at -5.3% per year, with a net decline across the window.
Bristol-Myers Squibb total assets peaked at $129.94B in 2019; the latest annual figure is $90.04B in 2025 (30.7% below peak).
The record annual total assets stands at $129.94B, reached in 2019; the historical low of $7.51B was recorded in 1987.
Bristol-Myers Squibb Total Assets by Year
Bristol-Myers Squibb Total Assets 2025: $90.04B
2025's total assets for Bristol-Myers Squibb came in at $90.04B, edged down 2.8% below 2024.
Bristol-Myers Squibb Total Assets 2024: $92.60B
Bristol-Myers Squibb posted total assets of $92.60B in 2024, edged down 2.7% below 2023.
Bristol-Myers Squibb Total Assets 2023: $95.16B
In 2023, Bristol-Myers Squibb reported total assets of $95.16B, edged down 1.7% below 2022.
Bristol-Myers Squibb Total Assets 2022: $96.82B
Bristol-Myers Squibb total assets in 2022 was $96.82B, declined 11.4% below 2021.
Bristol-Myers Squibb Total Assets 2021: $109.31B
Bristol-Myers Squibb total assets in 2021 was $109.31B.
See more financial history for Bristol-Myers Squibb (BMY).
Sector peers by Total Assets
Healthcare peers of Bristol-Myers Squibb (BMY), ranked by their latest total assets
| $309.58B | |
| $199.21B | |
| $136.87B | |
| $133.96B | |
| $114.07B | |
| $112.48B | |
| $90.59B | |
| $85.37B |
- $309.58B
- $199.21B
- $136.87B
- $133.96B
- $114.07B
- $112.48B
- $90.59B
- $85.37B
Frequently asked questions
Bristol-Myers Squibb (BMY) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation